Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02177838
Title Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications

larynx cancer

hypopharynx cancer

oropharynx cancer

Therapies

Cetuximab + Cisplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.